{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T13:54:14Z","timestamp":1694267654055},"reference-count":34,"publisher":"Index Copernicus","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngol Pol"],"published-print":{"date-parts":[[2016,7,10]]},"abstract":"<jats:p>Introduction: The objective of the paper is to evaluate the influence of the body mass index (BMI) on selected parameters\nof the coagulation system in patients with disorders of the balance system taking oral contraceptives.\nMaterial and methods: 105 young women participated in the study who were divided into 2 groups. Group I: 52 women\ndisorders of the balance system taking hormonal contraceptives for at least 2 months, between the age of 20\u201349;\nGroup II: 53 women with no disorders of the balance system taking hormonal contraceptives for at least 2 months, between\nthe age of 18\u201340. Patients entering the study underwent full otoneurological examination, detailed laryngological\nassessment and the examination of selected parameters of the hemostasis system, including the evaluation of\nfibrinogen and D-dimer levels, APTT and PT, estradiol and progesterone concentrations in the blood serum and evaluation\nof the body mass index (BMI).\nResults: Central vertigo was the most common type of vertigo in the study group (59,6% of cases). Other vertigo types\nin this group included compensated vertigo of mixed origin (36,6% of cases) and peripheral vertigo (only 3,8% of cases),\nwhich indicates that 40.4% of the cases suffer from damage to the labyrinth.\nThe analysis of the concentration of estradiol in the blood serum revealed, after consideration of a menstrual cycle\nphase, that estradiol concentration exceeded normative values significantly more often in the study group than in the\ncontrol group and that estradiol concentration was significantly less frequently below the norm in the study group;\nthe difference was statistically significant (p=0,048). The body mass index (BMI) of women participating in the study\nsignificantly correlated with the concentration of D-dimers only in the study group (p=0,35 vs p=0,012).\nConclusions: Evaluating the body mass index before administering hormonal contraception can be useful to eliminate\nother risk factors for thromboembolism. In order to prevent potential thromboembolism episodes, administering\nhormonal contraception only after lowering the body mass index may also be worth considering.\n\n<\/jats:p>","DOI":"10.5604\/00306657.1199345","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T11:54:02Z","timestamp":1461930842000},"page":"28-34","source":"Crossref","is-referenced-by-count":1,"title":["The influence of the body mass index (BMI) on selected\nparameters of the coagulation system in patients with\ndisorders of the balance system taking oral contraceptives"],"prefix":"10.5604","volume":"70","author":[{"given":"Marzena","family":"Bieli\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Urbaniak","sequence":"additional","affiliation":[{"name":"Klinka Otolaryngologii, Onkologii Laryngologicznej, Audiologii i Foniatrii Uniwersytetu Medycznego w \u0141odzi Kierownik kliniki: prof. dr hab. med. Jurek Olszewski"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Ku\u015bmierczyk","sequence":"additional","affiliation":[{"name":"Klinka Otolaryngologii, Onkologii Laryngologicznej, Audiologii i Foniatrii Uniwersytetu Medycznego w \u0141odzi Kierownik kliniki: prof. dr hab. med. Jurek Olszewski"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurek","family":"Olszewski","sequence":"additional","affiliation":[{"name":"Klinka Otolaryngologii, Onkologii Laryngologicznej, Audiologii i Foniatrii Uniwersytetu Medycznego w \u0141odzi Kierownik kliniki: prof. dr hab. med. Jurek Olszewski"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Pietkiewicz","sequence":"additional","affiliation":[{"name":"Klinka Otolaryngologii, Onkologii Laryngologicznej, Audiologii i Foniatrii Uniwersytetu Medycznego w \u0141odzi Kierownik kliniki: prof. dr hab. med. Jurek Olszewski"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","reference":[{"key":"119486r1","unstructured":"Bethesda M.: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. MedStar Physician Partners\/MedStarFamily Choice. 2007; 1\u201310."},{"key":"119486r2","unstructured":"Bethesda M.: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. MedStar Physician Partners\/MedStarFamily Choice. 2007; 1\u201310."},{"key":"119486r3","unstructured":"Jarosz M., K\u0142osiewicz-Latoszek L.: Oty\u0142o\u015b\u0107 \u2013 zapobieganie i leczenie. Wydawnictwo Lekarskie PZWL, Warszawa 2009; 10\u201325."},{"key":"119486r4","unstructured":"Jarosz M., K\u0142osiewicz-Latoszek L.: Oty\u0142o\u015b\u0107 \u2013 zapobieganie i leczenie. Wydawnictwo Lekarskie PZWL, Warszawa 2009; 10\u201325."},{"key":"119486r5","unstructured":"Kope\u0107 G., Podolec P.: Rozpowszechnienie nadwagi i oty\u0142o\u015bci w Polsce i na \u015bwiecie. Polskie Forum Profilaktyki Chor\u00f3b Uk\u0142adu Kr\u0105\u017cenia. 2007; 3(8): 3\u201325."},{"key":"119486r6","unstructured":"Kope\u0107 G., Podolec P.: Rozpowszechnienie nadwagi i oty\u0142o\u015bci w Polsce i na \u015bwiecie. Polskie Forum Profilaktyki Chor\u00f3b Uk\u0142adu Kr\u0105\u017cenia. 2007; 3(8): 3\u201325."},{"key":"119486r7","unstructured":"Szymocha M., Bry\u0142a M., Maniecka-Bry\u0142a I.: Epidemia oty\u0142o\u015bci w XXI wieku, Zdrowie Publiczne. 2009; 119 (2): 207\u2013212."},{"key":"119486r8","unstructured":"Szymocha M., Bry\u0142a M., Maniecka-Bry\u0142a I.: Epidemia oty\u0142o\u015bci w XXI wieku, Zdrowie Publiczne. 2009; 119 (2): 207\u2013212."},{"key":"119486r9","unstructured":"Sugiura K., Kobayashi T., Ojima T.: Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanesewomen. Thromb. Res. 2016; 137: 11\u201316."},{"key":"119486r10","unstructured":"Sugiura K., Kobayashi T., Ojima T.: Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanesewomen. Thromb. Res. 2016; 137: 11\u201316."},{"key":"119486r11","unstructured":"James P.T., Leach R., Kalamara E., Shayeghi M.: The worldwide obesity epidemic. Obesity Research. 2011; 9 (4): 228\u2013233."},{"key":"119486r12","unstructured":"James P.T., Leach R., Kalamara E., Shayeghi M.: The worldwide obesity epidemic. Obesity Research. 2011; 9 (4): 228\u2013233."},{"key":"119486r13","unstructured":"Grundy S.M.: Obesity, metabolic syndrome and cardiovascular disease. J. Clin. Endocrinol.&Metabolism. 2004; 89 (6): 2595\u20132600."},{"key":"119486r14","unstructured":"Grundy S.M.: Obesity, metabolic syndrome and cardiovascular disease. J. Clin. Endocrinol.&Metabolism. 2004; 89 (6): 2595\u20132600."},{"key":"119486r15","doi-asserted-by":"crossref","unstructured":"Holst A.G., Jensen G., Prescott E.: Risk factors for venous thromboembolism. Results from the Copenhagen City Heart Study. Circulation. 2010; 121:1896\u20131903.","DOI":"10.1161\/CIRCULATIONAHA.109.921460"},{"key":"119486r16","doi-asserted-by":"crossref","unstructured":"Holst A.G., Jensen G., Prescott E.: Risk factors for venous thromboembolism. Results from the Copenhagen City Heart Study. Circulation. 2010; 121:1896\u20131903.","DOI":"10.1161\/CIRCULATIONAHA.109.921460"},{"key":"119486r17","unstructured":"Rocha A.T., Paiva E.F., Lichtenstein A., Milani R. Jr, Cavalheiro C.F., Maffei F.H.: Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag. 2007; 3(4): 533\u2013553."},{"key":"119486r18","unstructured":"Rocha A.T., Paiva E.F., Lichtenstein A., Milani R. Jr, Cavalheiro C.F., Maffei F.H.: Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag. 2007; 3(4): 533\u2013553."},{"key":"119486r19","unstructured":"Pouchain D, Bergmann JF, Bosson JL.: Prevalence and prevention of venous thromboembolic events in general practice. Multicenter, prospective cohortstudy. Rev. Prat. 2008; 58 (19 Suppl.): 3\u20138."},{"key":"119486r20","unstructured":"Pouchain D, Bergmann JF, Bosson JL.: Prevalence and prevention of venous thromboembolic events in general practice. Multicenter, prospective cohortstudy. Rev. Prat. 2008; 58 (19 Suppl.): 3\u20138."},{"key":"119486r21","doi-asserted-by":"crossref","unstructured":"Squizzato A.: Thromboprophylaxis in day surgery. Intern. J. Surg. 2008; 6 (1) Suppl.: 29\u201330.","DOI":"10.1016\/j.ijsu.2008.12.020"},{"key":"119486r22","doi-asserted-by":"crossref","unstructured":"Squizzato A.: Thromboprophylaxis in day surgery. Intern. J. Surg. 2008; 6 (1) Suppl.: 29\u201330.","DOI":"10.1016\/j.ijsu.2008.12.020"},{"key":"119486r23","doi-asserted-by":"crossref","unstructured":"Ahrendt H.J., Nisand I., Bastianelli C. et al.: Efficacy, acceptability and tolerability of the combined contraceptive ring. Contraception. 2006; 74 (6):451\u2013457.","DOI":"10.1016\/j.contraception.2006.07.004"},{"key":"119486r24","doi-asserted-by":"crossref","unstructured":"Ahrendt H.J., Nisand I., Bastianelli C. et al.: Efficacy, acceptability and tolerability of the combined contraceptive ring. Contraception. 2006; 74 (6):451\u2013457.","DOI":"10.1016\/j.contraception.2006.07.004"},{"key":"119486r25","unstructured":"Urbaniak J., Zieli\u0144ska-Bli\u017aniewska H., Pietkiewicz P., Olszewski J.: Wp\u0142yw dzia\u0142ania doustnych \u015brodk\u00f3w antykoncepcyjnych na wybrane parametry uk\u0142aduhemostazy u m\u0142odych kobiet z nag\u0142ym zaburzeniem czynno\u015bci uk\u0142adu r\u00f3wnowagi. Otolaryngol. Pol. 2013; 67 (1): 25\u201329."},{"key":"119486r26","unstructured":"Urbaniak J., Zieli\u0144ska-Bli\u017aniewska H., Pietkiewicz P., Olszewski J.: Wp\u0142yw dzia\u0142ania doustnych \u015brodk\u00f3w antykoncepcyjnych na wybrane parametry uk\u0142aduhemostazy u m\u0142odych kobiet z nag\u0142ym zaburzeniem czynno\u015bci uk\u0142adu r\u00f3wnowagi. Otolaryngol. Pol. 2013; 67 (1): 25\u201329."},{"key":"119486r27","unstructured":"Cibula D.: Women\u2019s contraceptive practices and sexual behaviour in Europe. Eur. J. Contracept Reprod. Health Care. 2008; 13 (4): 362\u2013375."},{"key":"119486r28","unstructured":"Cibula D.: Women\u2019s contraceptive practices and sexual behaviour in Europe. Eur. J. Contracept Reprod. Health Care. 2008; 13 (4): 362\u2013375."},{"key":"119486r29","unstructured":"Mansour D., Inki P., Gemzell-Danielsson K.: Efficacy of contraceptive methods: A review of the literature. Eur. J. Contracept Reprod. Health Care. 2010; 15(1): 4\u201316."},{"key":"119486r30","unstructured":"Mansour D., Inki P., Gemzell-Danielsson K.: Efficacy of contraceptive methods: A review of the literature. Eur. J. Contracept Reprod. Health Care. 2010; 15(1): 4\u201316."},{"key":"119486r31","doi-asserted-by":"crossref","unstructured":"Nakajima S.T., Pappadakis J., Archer D.F.: Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oralcontraceptive. Contraception. 2016; 93 (1): 52\u201357.","DOI":"10.1016\/j.contraception.2015.09.013"},{"key":"119486r32","doi-asserted-by":"crossref","unstructured":"Nakajima S.T., Pappadakis J., Archer D.F.: Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oralcontraceptive. Contraception. 2016; 93 (1): 52\u201357.","DOI":"10.1016\/j.contraception.2015.09.013"},{"key":"119486r33","doi-asserted-by":"crossref","unstructured":"Kohn J.E., Lopez P.M., Simons H.R.: Weight and body mass index among female contraceptive clients. Contraception, 2015; 91 (6): 470\u2013473.","DOI":"10.1016\/j.contraception.2015.02.006"},{"key":"119486r34","doi-asserted-by":"crossref","unstructured":"Kohn J.E., Lopez P.M., Simons H.R.: Weight and body mass index among female contraceptive clients. Contraception, 2015; 91 (6): 470\u2013473.","DOI":"10.1016\/j.contraception.2015.02.006"}],"container-title":["Otolaryngologia Polska"],"original-title":[],"link":[{"URL":"https:\/\/publisherspanel.com\/gicid\/pdf\/01.3001.0008.2769","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publisherspanel.com\/gicid\/pdf\/01.3001.0008.2769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T11:46:41Z","timestamp":1561722401000},"score":1,"resource":{"primary":{"URL":"https:\/\/publisherspanel.com\/gicid\/01.3001.0008.2769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7,10]]}},"URL":"https:\/\/doi.org\/10.5604\/00306657.1199345","relation":{},"ISSN":["0030-6657","2300-8423"],"issn-type":[{"value":"0030-6657","type":"print"},{"value":"2300-8423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,10]]}}}